APDN
Price
$1.34
Change
-$0.32 (-19.28%)
Updated
Apr 4, 11:52 AM (EDT)
Capitalization
7.13M
PRPO
Price
$5.00
Change
-$0.15 (-2.91%)
Updated
Apr 4, 10:30 AM (EDT)
Capitalization
9.51M
Ad is loading...

APDN vs PRPO

Header iconAPDN vs PRPO Comparison
Open Charts APDN vs PRPOBanner chart's image
Applied DNA Sciences
Price$1.34
Change-$0.32 (-19.28%)
Volume$26.08K
Capitalization7.13M
Precipio
Price$5.00
Change-$0.15 (-2.91%)
VolumeN/A
Capitalization9.51M
APDN vs PRPO Comparison Chart
Loading...
APDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRPO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APDN vs. PRPO commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APDN is a Hold and PRPO is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (APDN: $1.66 vs. PRPO: $5.15)
Brand notoriety: APDN and PRPO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: APDN: 363% vs. PRPO: 49%
Market capitalization -- APDN: $7.13M vs. PRPO: $9.51M
APDN [@Medical Specialties] is valued at $7.13M. PRPO’s [@Medical Specialties] market capitalization is $9.51M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APDN’s FA Score shows that 1 FA rating(s) are green whilePRPO’s FA Score has 1 green FA rating(s).

  • APDN’s FA Score: 1 green, 4 red.
  • PRPO’s FA Score: 1 green, 4 red.
According to our system of comparison, PRPO is a better buy in the long-term than APDN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APDN’s TA Score shows that 5 TA indicator(s) are bullish while PRPO’s TA Score has 3 bullish TA indicator(s).

  • APDN’s TA Score: 5 bullish, 3 bearish.
  • PRPO’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, APDN is a better buy in the short-term than PRPO.

Price Growth

APDN (@Medical Specialties) experienced а -11.23% price change this week, while PRPO (@Medical Specialties) price change was -17.74% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -6.14%. For the same industry, the average monthly price growth was -2.63%, and the average quarterly price growth was -1.91%.

Reported Earning Dates

APDN is expected to report earnings on Aug 08, 2024.

PRPO is expected to report earnings on Nov 13, 2023.

Industries' Descriptions

@Medical Specialties (-6.14% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRPO($9.52M) has a higher market cap than APDN($7.13M). PRPO YTD gains are higher at: -7.036 vs. APDN (-83.725). PRPO has higher annual earnings (EBITDA): -7.52M vs. APDN (-12.2M). APDN has more cash in the bank: 3.36M vs. PRPO (1.56M). APDN has less debt than PRPO: APDN (1.12M) vs PRPO (1.3M). PRPO has higher revenues than APDN: PRPO (13.3M) vs APDN (9M).
APDNPRPOAPDN / PRPO
Capitalization7.13M9.52M75%
EBITDA-12.2M-7.52M162%
Gain YTD-83.725-7.0361,190%
P/E RatioN/AN/A-
Revenue9M13.3M68%
Total Cash3.36M1.56M215%
Total Debt1.12M1.3M86%
FUNDAMENTALS RATINGS
APDN vs PRPO: Fundamental Ratings
APDN
PRPO
OUTLOOK RATING
1..100
6268
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10095
PRICE GROWTH RATING
1..100
9964
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APDN's Valuation (23) in the Information Technology Services industry is in the same range as PRPO (28) in the Biotechnology industry. This means that APDN’s stock grew similarly to PRPO’s over the last 12 months.

APDN's Profit vs Risk Rating (100) in the Information Technology Services industry is in the same range as PRPO (100) in the Biotechnology industry. This means that APDN’s stock grew similarly to PRPO’s over the last 12 months.

PRPO's SMR Rating (95) in the Biotechnology industry is in the same range as APDN (100) in the Information Technology Services industry. This means that PRPO’s stock grew similarly to APDN’s over the last 12 months.

PRPO's Price Growth Rating (64) in the Biotechnology industry is somewhat better than the same rating for APDN (99) in the Information Technology Services industry. This means that PRPO’s stock grew somewhat faster than APDN’s over the last 12 months.

PRPO's P/E Growth Rating (100) in the Biotechnology industry is in the same range as APDN (100) in the Information Technology Services industry. This means that PRPO’s stock grew similarly to APDN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APDNPRPO
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 8 days ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 8 days ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 8 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 8 days ago
86%
Advances
ODDS (%)
Bullish Trend 25 days ago
79%
Bullish Trend 19 days ago
80%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 9 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 8 days ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 8 days ago
85%
View a ticker or compare two or three
Ad is loading...
APDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRPO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EIVCX13.08N/A
N/A
Allspring Special Large Cap Value C
HISCX25.83N/A
N/A
Hartford Small Cap Growth HLS IA
TMPIX53.62N/A
N/A
Touchstone Mid Cap Institutional
SAPEX17.80N/A
N/A
Spectrum Active Advantage Investor
TNVIX16.42N/A
N/A
1290 GAMCO Small/Mid Cap Value I